Federated Hermes, Inc. Iovance Biotherapeutics, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$5.62 - $10.0 $59,959 - $106,690	10,669 New	10,669 $68,000
Q2 2022 Aug 15, 2022	SELL	$6.38 - $18.33 $100,599 - $289,027	-15,768 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$12.38 - $19.1 $195,207 - $301,168	15,768 New	15,768 $263,000
Q2 2021 Aug 16, 2021	SELL	$16.33 - $33.07 $441,187 - $893,452	-27,017 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$28.67 - $52.59 $113,189 - $207,625	-3,948 Reduced 12.75%	27,017 $855,000
Q4 2020 Feb 12, 2021	BUY	$28.04 - $50.26 $409,299 - $733,645	14,597 Added 89.18%	30,965 $1.44 Million
Q3 2020 Nov 12, 2020	SELL	$27.75 - $36.3 $804 - $1,052	-29 Reduced 0.18%	16,368 $539,000
Q2 2020 Aug 13, 2020	BUY	$27.21 - $41.0 $446,162 - $672,277	16,397 New	16,397 $450,000
Q1 2020 May 13, 2020	SELL	$19.54 - $38.85 $2,931 - $5,827	-150 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$17.95 - $29.41 $794,772 - $1.3 Million	-44,277 Reduced 99.66%	150 $4,000
Q3 2019 Nov 14, 2019	SELL	$17.99 - $26.0 $5.37 Million - $7.76 Million	-298,456 Reduced 87.04%	44,427 $809,000
Q2 2019 Aug 14, 2019	BUY	$9.78 - $24.52 $3.35 Million - $8.4 Million	342,421 Added 74117.1%	342,883 $8.41 Million
Q1 2019 May 10, 2019	SELL	$8.41 - $11.26 $361 - $484	-43 Reduced 8.51%	462 $4,000
Q4 2018 Feb 13, 2019	SELL	$7.51 - $11.93 $236,527 - $375,735	-31,495 Reduced 98.42%	505 $4,000
Q3 2018 Nov 13, 2018	SELL	$11.25 - $17.7 $651,498 - $1.03 Million	-57,911 Reduced 64.41%	32,000 $360,000
Q2 2018 Aug 10, 2018	BUY	$12.45 - $16.95 $294,554 - $401,020	23,659 Added 35.71%	89,911 $1.15 Million
Q1 2018 May 09, 2018	BUY	$8.1 - $19.5 $532,890 - $1.28 Million	65,789 Added 14209.29%	66,252 $1.12 Million
Q4 2017 Feb 14, 2018	BUY	$6.65 - $9.25 $3,078 - $4,282	463	463 $0

Others Institutions Holding IOVA

# of Institutions

314

Shares Held

241M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.35B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account